STORM Therapeutics

1 Follower


STORM Therapeutics is a pioneer in the field of RNA epigenetics. We are an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.

Keith Blundy
Director and Chief Executive Officer
Keith Blundy
Angus Lauder
Director of Business Development
Josefin-Beate Holz
Chief Medical Officer
Mark Albertella
Vice President, Translational Oncology
Oliver Rausch
Chief Scientific Officer
Dan Leggate
Head of Discovery Biology

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.